Sinovac Biotech, Ltd. · NASDAQ:SVA

Vivo Capital VIII, LLC reported a 1.90% stake in Sinovac Biotech, Ltd. (Schedule 13D/A)

Event Jul 11, 2025 · Filed Jul 11, 2025

Vivo Capital VIII, LLC reported a 1.90% stake in Sinovac Biotech, Ltd., 1,361,236 shares, with active intent on Jul 11, 2025. Filed Jul 11, 2025 (Schedule 13D/A).

Stake
1.90%
Shares
1,361,236
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Vivo Capital VIII, LLC1.90%1,361,236
Vivo Capital IX, LLC6.30%4,541,764

Source

View original at SEC

Related